No Data
No Data
NeurAxis Announces Molina Healthcare Coverage For PENFS Therapy IB-Stim, FDA-Cleared For Treating Abdominal Pain In IBS Adolescents
NeurAxis Announces New Medical Policy Coverage With Molina Healthcare for Over Five Million Lives Across Multiple States
NeurAxis, Inc. CEO Brian Carrico Shares 2024 Achievements and Vision for 2025 in Shareholder Letter
NeurAxis Inc. Issues Letter to Shareholders
Neuraxis | 8-K: NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
Neuraxis Sees 4Q Rev $800,000 >NRXS
Unlock the Full List